Cent Eur J Public Health 2026, 34(1):53-58 | DOI: 10.21101/cejph.a8574

Atherosclerosis and dementia development: an epidemiological case-control study

Veronika Koutná1, Ladislav Štěpánek1, Martina Kovalová2, 3, 4, Ondřej Machaczka2, 3, Petr Ambroz2, 3, Anna Zatloukalová2, 3, Eva Mrázková4, Michal Bar5, Martin Roubec5, 6, Petra Bártová5, Richard Novobilský5, 6, Martin Sabela5, 6, Pavlína Kušnierová7, 8, David Stejskal7, 8, Lucie Faldynová9, Sylwia Walczysková9, Lukáš Školoudík10, 11, Libor Šimůnek11, Petra Šolínová11, David Školoudík12, Jana Janoutová1, Vladimír Janout1
1 Department of Public Health, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic
2 Science and Research Centre, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic
3 Department of Healthcare Management and Public Health, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic
4 Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
5 Department of Neurology, University Hospital Ostrava, Ostrava, Czech Republic
6 Department of Clinical Neurosciences, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
7 Department of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic
8 Department of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
9 Department of Clinical and Molecular Pathology and Medical Genetics, University Hospital Ostrava, Ostrava, Czech Republic
10 Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
11 University Hospital Hradec Králové, Hradec Králové, Czech Republic
12 Centre for Health Research, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

Objectives: With increasing life expectancy, the prevalence of atherosclerosis and dementia is expected to rise in the future and as such represents a public health threat. This study focused on analysis of atherosclerosis risk factors and the protective factors of leisure-time activities in the development of dementia.

Methods: The sample comprised 1,298 participants that were selected from university hospitals and outpatient clinics between 2019-2023. All participants completed a questionnaire and medical data were obtained. We used logistic regression to identify dementia risk factors and we also compared the leisure-time protective factors between four groups based on the presence of atherosclerosis and/or dementia.

Results: Hypercholesterolemia (aOR = 3.25, p > 0.001), stroke (aOR = 1.43, p = 0.015), and carotid stenosis (aOR = 2.23, p > 0.001) were significantly associated with risk of dementia whereas age (aOR = 0.93, p < 0.001) and female gender (aOR = 0.70, p = 0.012) were negatively associated. The model of these factors demonstrated moderate discriminatory ability of AUC 0.737 (95% CI: 0.702-0.769). Higher education levels and regular cognitive and physical activities such as reading and exercise had positive effects against dementia.

Conclusion: These findings accentuate the importance of cardiovascular health in reducing risk of dementia. Preventive strategies targeting hypercholesterolemia, carotid stenosis and inactivity, along with promotion of cognitive engagement and education, could substantially reduce the global burden of dementia.

Klíčová slova: cognitive decline, dementia, epidemiology, public health, prevention, atherosclerosis

Vloženo: 27. únor 2025; Revidováno: 30. září 2025; Přijato: 30. září 2025; Zveřejněno: 31. březen 2026  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Koutná V, Štěpánek L, Kovalová M, Machaczka O, Ambroz P, Zatloukalová A, et al.. Atherosclerosis and dementia development: an epidemiological case-control study. Cent Eur J Public Health. 2026;34(1):53-58. doi: 10.21101/cejph.a8574.
Stáhnout citaci

Reference

  1. Alzheimer's Disease International. World Alzheimer report 2024: global changes in attitudes to dementia [Internet]. London: Alzheimer's Disease International; 2024 [cited 2025 Sep 30]. Available from: https://www.alzint.org/u/World-Alzheimer-Report-2024.pdf.
  2. Walsh S, Govia I, Peters R, Richard E, Stephan BCM, Wilson NA, et al. What would a population-level approach to dementia risk reduction look like, and how would it work? Alzheimers Dement. 2023 Jul:19(7):3203-9. Přejít k původnímu zdroji...
  3. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8;396(10248):413-46. Přejít k původnímu zdroji...
  4. Baradaran H, Dahlstrom KA, Culleton S, Sarrami AH, McFarland MM, Romero JR. Association between extracranial carotid artery plaque and cognitive dysfunction: a systematic review and meta-analysis. Dement Geriatr Cogn Disord. 2022;51(5):377-85. Přejít k původnímu zdroji...
  5. Bahrami A, Barreto GE, Lombardi G, Pirro M, Sahebkar A. Emerging roles for high-density lipoproteins in neurodegenerative disorders. Biofactors. 2019 Sep;45(5):725-39. Přejít k původnímu zdroji...
  6. Nordestgaard LT, Christoffersen M, Afzal S, Nordestgaard BG, Tybjærg-Hansen A, Frikke-Schmidt R. Triglycerides as a shared risk factor between dementia and atherosclerotic cardiovascular disease: a study of 125 727 Individuals. Clin Chem. 2021 Jan 8;67(1):245-55. Přejít k původnímu zdroji...
  7. Hahad O, Schmitt VH, Arnold N, Keller K, Prochaska JH, Wild PS, et al. Chronic cigarette smoking is associated with increased arterial stiffness in men and women: evidence from a large population-based cohort. Clin Res Cardiol. 2023 Feb;112(2):270-84. Přejít k původnímu zdroji...
  8. Litkowski EM, Logue MW, Zhang R, Charest BR, Lange EM, Hokanson JE, et al. Mendelian randomization study of diabetes and dementia in the Million Veteran Program. Alzheimers Dement. 2023 Oct;19(10):4367-76. Přejít k původnímu zdroji...
  9. Wang Y, Li C, Liang J, Gao D, Pan Y, Zhang W, et al. Onset age of diabetes and incident dementia: a prospective cohort study. J Affect Disord. 2023 May 15;329:493-9. Přejít k původnímu zdroji...
  10. Lövdén M, Fratiglioni L, Glymour MM, Lindenberger U, Tucker-Drob EM. Education and cognitive functioning across the life span. Psychol Sci Public Interest. 2020 Aug;21(1):6-41. Přejít k původnímu zdroji...
  11. Janoutová J, Kovalová M, Machaczka O, Ambroz P, Zatloukalová A, Němček K, et al. Risk factors for Alzheimer's disease: an epidemiological study. Curr Alzheimer Res. 2021;18(5):372-9. Přejít k původnímu zdroji...
  12. Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015 Jun;11(6):718-26. Přejít k původnímu zdroji...
  13. Liu C, Ma Y, Hofman A, Waziry R, Koton S, Pike JR, et al. Educational attainment and dementia: mediation by mid-life vascular risk factors. Ann Neurol. 2023 Jul;94(1):13-26. Přejít k původnímu zdroji...
  14. Hoenig MC, Bischof GN, Onur ÖA, Kukolja J, Jessen F, Fliessbach K, et al. Level of education mitigates the impact of tau pathology on neuronal function. Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1787-95. Přejít k původnímu zdroji...
  15. Leibovici D, Ritchie K, Ledésert B, Touchon J. Does education level determine the course of cognitive decline? Age Ageing. 1996 Sep;25(5):392-7. Přejít k původnímu zdroji...
  16. Yaffe K, Vittinghoff E, Hoang T, Matthews K, Golden SH, Zeki Al Hazzouri A. Cardiovascular risk factors across the life course and cognitive decline: a pooled cohort study. Neurology. 2021 Apr 27;96(17):e2212-9. Přejít k původnímu zdroji...
  17. Razo C, Welgan CA, Johnson CO, McLaughlin SA, Iannucci V, Rodgers A, et al. Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study. Nat Med. 2022 Oct;28(10):2056-65. Přejít k původnímu zdroji...
  18. Moberg L, Leppert J, Liljeström S, Rehn M, Kilander L, Chabok A. Blood pressure screening in midlife aids in prediction of dementia later in life. Ups J Med Sci. 2022 Jan 3;127. doi: 10.48101/ujms.v127.7860. Přejít k původnímu zdroji...
  19. Brain J, Greene L, Tang EYH, Louise J, Salter A, Beach S, et al. Cardiovascular disease, associated risk factors, and risk of dementia: an umbrella review of meta-analyses. Front Epidemiol. 2023 Feb 9;3:1095236. doi: 10.3389/fepid.2023.1095236. Přejít k původnímu zdroji...
  20. McGrath ER, Beiser AS, DeCarli C, Plourde KL, Vasan RS, Greenberg SM, et al. Blood pressure from mid- to late life and risk of incident dementia. Neurology. 2017 Dec 12;89(24):2447-54. Přejít k původnímu zdroji...
  21. Donato AJ, Machin DR, Lesniewski LA. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ Res. 2018 Sep14;123(7):825-48. Přejít k původnímu zdroji...
  22. Verhaaren BF, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension. 2013 Jun;61(6):1354-9. Přejít k původnímu zdroji...
  23. Gustavsson AM, van Westen D, Stomrud E, Engström G, Nägga K, Hansson O. Midlife atherosclerosis and development of Alzheimer or vascular dementia. Ann Neurol. 2020 Jan;87(1):52-62. Přejít k původnímu zdroji...
  24. Perna L, Mons U, Stocker H, Beyer L, Beyreuther K, Trares K, et al. High cholesterol levels change the association of biomarkers of neurodegenerative diseases with dementia risk: findings from a population-based cohort. Alzheimers Dement. 2023 Jul;19(7):2913-22. Přejít k původnímu zdroji...
  25. Zamrini E, McGwin G, Roseman JM. Association between statin use and Alzheimer's disease. Neuroepidemiology. 2004 Jan-Apr;23(1-2):94-8. Přejít k původnímu zdroji...
  26. Poly TN, Islam MM, Walther BA, Yang HC, Wu CC, Lin MC, et al. Association between use of statin and risk of dementia: a meta-analysis of observational studies. Neuroepidemiology. 2020;54(3):214-26. Přejít k původnímu zdroji...
  27. Wee J, Sukudom S, Bhat S, Marklund M, Peiris NJ, Hoyos CM, et al. The relationship between midlife dyslipidemia and lifetime incidence of dementia: a systematic review and meta-analysis of cohort studies. Alzheimers Dement (Amst). 2023 Mar 8;15(1):e12395. doi: 10.1002/dad2.12395. Přejít k původnímu zdroji...
  28. Boivin-Proulx LA, Brouillette J, Dorais M, Perreault S. Association between cardiovascular diseases and dementia among various age groups: a population-based cohort study in older adults. Sci Rep. 2023 Sep 9;13(1):14881. doi: 10.1038/s41598-023-42071-8. Přejít k původnímu zdroji...
  29. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Hearth Association/American Stroke Association. Stroke. 2011 Sep;42(9):2672-713.
  30. Saint-Maurice PF, Coughlan D, Kelly SP, Keadle SK, Cook MB, Carlson SA, et al. Association of leisure-time physical activity across the adult life course with all-cause and cause-specific mortality. JAMA Netw Open. 2019 Mar 1;2(3):e190355. doi: 10.1001/jamanetworkopen.2019.0355. Přejít k původnímu zdroji...
  31. Lundberg K, Elmståhl S, Wranker LS, Ekström H. The Association between physical frailty and cognitive performance in older adults aged 60 to 96 years: data from the "Good Aging in Skåne" (GÅS) Swedish Population Study. Ann Geriatr Med Res. 2024 Sep;28(3):330-41. Přejít k původnímu zdroji...